James Kuiken
Director/Board Member at COLUMBIA FINANCIAL, INC.
Net worth: 216 758 $ as of 2024-04-29
Profile
James M.
Kuiken has worked as an Independent Non-Executive Director at Columbia Financial, Inc. since 2020 and as an Operations Director at Roche Molecular Systems, Inc. since 1996.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
COLUMBIA FINANCIAL, INC.
0.01% | 2024-04-14 | 12,864 ( 0.01% ) | 216 758 $ | 2024-04-29 |
James Kuiken active positions
Companies | Position | Start |
---|---|---|
COLUMBIA FINANCIAL, INC. | Director/Board Member | 2020-05-21 |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Chief Operating Officer | 2014-03-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
COLUMBIA FINANCIAL, INC. | Finance |
Private companies | 1 |
---|---|
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
- Stock Market
- Insiders
- James Kuiken